NEW YORK (CNNMoney) -- The Swiss drugmaker Novartis is cutting nearly 2,000 jobs in the United States, anticipating the impending loss of patent protection on its blockbuster drug Diovan.
Novartis (NVS) said it is reducing its "field force" by 1,630 positions and cutting an additional 330 jobs at its headquarters. Though the company did not specify where exactly these job cuts would take place, its U.S. headquarters is in East Hanover, N.J., and it also has facilities in Massachusetts and California.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
Never heard of it.
ReplyDeletethey had a huge recall this week, Excedrin, No-dos.
ReplyDelete